ACTRN12605000478617已完成3 期
ANZ 9311. Phase III trial to compare the effect of a short high dose intensive course of chemotherapy with filgrastim support versus a conventional standard dose course of chemotherapy in patients with advanced breast cancer.
Australia and New Zealand Breast Cancer Trials Group Ltd0 个研究点目标入组 225 人开始时间: 2005年9月23日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 225
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- Female
入选标准
- •Histologically proven primary breast cancer with recurrent and/or metastatic disease; no more than one previous cytotoxic chemotherapy regimen for recurrent or metastatic disease; disease must be measurable or evaluable; patient must be geographically accessible for follow up; written informed consent provided.
排除标准
- •Past or recurrent malignancies at other sites, except adequately treated squamous or basal cell carcinoma of the skin, or carcinoma in situ of the cervix; radiotherapy in excess of regional therapy to primary disease, cranial therapy or limited localized therapy; patients whose only demonstrable disease is intracranial.
研究者
相似试验
已完成
3 期
ANZ 8811: A Phase III study to compare the effect of Zoladex depot (ICI 118,630) with Nolvadex plus Zoladex depot in pre- and peri-menopausal patients with advanced breast cancer.Advanced breast cancerCancer - BreastACTRN12606000499583Australian New Zealand Breast Cancer Trials Group (ANZ BCTG)180
已完成
3 期
PROphylaxis of ThromboEmbolism in Critical Care Trial (PROTECT)ThromboembolismCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemACTRN12606000090516McMaster University3,650
进行中（未招募）
1 期
Clinical study phase III evaluating the efficacy of Diffusil H Forte sprayEUCTR2007-002478-76-CZybar a.s.110
已完成
不适用
euprolide acetate 3 month depot medicine use in advance prostate cancerCTRI/2021/07/034710Bharat Serums and Vaccines ltd8
招募中
1 期
A study to compare nemtabrutinib to standard cancer treatments in people with untreated blood cancerChronic lymphocytic leukemia/ small lymphocytic lymphomaMedDRA version: 21.1Level: LLTClassification code: 10003910Term: B-cell small lymphocytic lymphoma NOS Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10008976Term: Chronic lymphocytic leukemia Class: 10029104CTIS2022-501481-21-00Merck Sharp & Dohme LLC212